{
    "title": "EU drug regulator OKs Pfizer COVID pill for high-risk patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10448323/EU-drug-regulator-green-lights-Pfizers-COVID-19-pill.html",
    "date": "2022-01-27",
    "keywords": [
        "drug",
        "paxlovid",
        "regulator",
        "risk",
        "use",
        "trial",
        "jan",
        "covid19",
        "pill",
        "illness",
        "omicron",
        "endorsement",
        "emergency",
        "germany",
        "health",
        "home",
        "reporting",
        "thursday",
        "light",
        "region",
        "agency",
        "ema",
        "approval",
        "commission",
        "member",
        "guidance",
        "year",
        "belgium",
        "handful",
        "december",
        "molnupiravir",
        "commissioner",
        "stella",
        "bloc",
        "progress",
        "line",
        "defence",
        "antiviral",
        "portfolio",
        "difference",
        "progression",
        "covid",
        "review",
        "eu",
        "company",
        "november",
        "treatment",
        "onset",
        "manufacturing",
        "footprint",
        "europe",
        "production",
        "executive",
        "albert",
        "bourla",
        "statement",
        "companys",
        "lab",
        "effectiveness",
        "variant",
        "minister",
        "lauterbach",
        "goahead",
        "end",
        "month",
        "rollout",
        "italy",
        "option",
        "roy",
        "manas",
        "mishra",
        "bengaluru",
        "ludwig",
        "burger",
        "dasgupta",
        "bernadette",
        "baum",
        "mark",
        "porter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}